These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 10455368

  • 1. Factors that influence long-term hematopoietic function following autologous stem cell transplantation.
    Amigo ML, del Cañizo MC, Caballero MD, Vazquez L, Corral M, Vidriales B, Brufau A, San Miguel JF.
    Bone Marrow Transplant; 1999 Aug; 24(3):289-93. PubMed ID: 10455368
    [Abstract] [Full Text] [Related]

  • 2. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 3. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
    Mayer J, Korístek Z, Pospísil Z, Vásová I, Adam Z, Hájek R, Krejcí M, Král Z, Navrátil M, Vorlícek J, Bourková L, Matýsková M, Adler J, Vinklárková J, Klabusay M, Koutná I, Hoffová V, Schmitzová D, Janovská E.
    Cas Lek Cesk; 1999 Mar 15; 138(6):170-7. PubMed ID: 10510531
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A, de la Rubia J, Martín G, Martínez J, Sanz G, Jarque I, Sempere A, Soler MA, Marty ML, Sanz MA.
    Bone Marrow Transplant; 2002 May 15; 29(10):825-32. PubMed ID: 12058232
    [Abstract] [Full Text] [Related]

  • 5. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 6. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation.
    del Cañizo C, Lopez N, Caballero D, Fernandez E, Brufau A, Vazquez L, Mateos V, Gutierrez N, San Miguel JF.
    Bone Marrow Transplant; 1999 May 15; 23(9):901-5. PubMed ID: 10338045
    [Abstract] [Full Text] [Related]

  • 7. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA, Sims-Poston L, Eldridge P, Hale GA.
    Biol Blood Marrow Transplant; 2007 May 15; 13(5):608-14. PubMed ID: 17448921
    [Abstract] [Full Text] [Related]

  • 8. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H.
    Eur J Haematol; 2007 Jan 15; 78(1):21-8. PubMed ID: 17042762
    [Abstract] [Full Text] [Related]

  • 9. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
    Nieboer P, de Vries EG, Mulder NH, Sleijfer DT, Willemse PH, Hospers GA, Gietema JA, Sluiter WJ, van Der Graaf WT.
    Bone Marrow Transplant; 2001 May 15; 27(9):959-66. PubMed ID: 11436106
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery.
    del Cañizo MC, Lopez N, Vazquez L, Fernandez ME, Ana B, Caballero MD, Amigo ML, Mateos MV, Gutierrez N, San Migue JF.
    Haematologica; 1999 Jun 15; 84(6):511-6. PubMed ID: 10366794
    [Abstract] [Full Text] [Related]

  • 11. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Yoon DH, Sohn BS, Jang G, Kim EK, Kang BW, Kim C, Kim JE, Kim S, Lee DH, Lee JS, Park SJ, Park CJ, Huh J, Suh C.
    Transfusion; 2009 Sep 15; 49(9):1890-900. PubMed ID: 19453991
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support.
    Consolini R, Calleri A, Bengala C, Legitimo A, Conte PF.
    Haematologica; 2001 Sep 15; 86(9):959-64. PubMed ID: 11532624
    [Abstract] [Full Text] [Related]

  • 13. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.
    Transfusion; 2007 Dec 15; 47(12):2207-16. PubMed ID: 17714420
    [Abstract] [Full Text] [Related]

  • 14. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J.
    Transfusion; 2006 Nov 15; 46(11):1934-42. PubMed ID: 17076849
    [Abstract] [Full Text] [Related]

  • 15. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J, Cartron G, Clement N, Estienne MH, Herault O, Truglio D, Benboubker L, Roingeard F, Desbois I, Colombat P, Binet C.
    Bone Marrow Transplant; 2002 Apr 15; 29(7):557-62. PubMed ID: 11979303
    [Abstract] [Full Text] [Related]

  • 16. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
    Zubair AC, Kao G, Daley H, Schott D, Freedman A, Ritz J.
    Cytotherapy; 2006 Apr 15; 8(4):399-407. PubMed ID: 16923616
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, Fruehauf S, Ho AD.
    Stem Cells; 2007 Jan 15; 25(1):228-35. PubMed ID: 17204607
    [Abstract] [Full Text] [Related]

  • 18. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
    Del Cañizo Mf, Amigo Mf, Hernández JM, Sanz G, Núñez R, Carreras E, Alegre A, Cuesta B, Mataix R.
    Haematologica; 2000 Apr 15; 85(4):403-9. PubMed ID: 10756367
    [Abstract] [Full Text] [Related]

  • 19. Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer.
    Okumura A, Tokuda Y, Ohta M, Suzuki Y, Saito Y, Kuge S, Kubota M, Makuuchi H, Tajima T, Nakamura Y, Hotta T.
    Tokai J Exp Clin Med; 1999 Dec 15; 24(4-6):141-6. PubMed ID: 10819494
    [Abstract] [Full Text] [Related]

  • 20. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H, Wake A, Yamasaki Y, Izumi Y.
    Rinsho Ketsueki; 2000 Jun 15; 41(6):500-6. PubMed ID: 10921350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.